Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Malignant Melanoma

Free Subscription 14.06.2021 2 Ann Surg Oncol 4 BMC Cancer 1 BMC Ophthalmol 1 Br J Cancer 5 Br J Dermatol 2 Cancer Res 3 Clin Cancer Res 1 Clin Exp Metastasis 1 Cutis 1 Eur J Dermatol 5 J Am Acad Dermatol 1 J Clin Oncol 2 J Surg Oncol 4 Melanoma Res 1 N Engl J Med 1 Oncol Rep 1 Ophthalmol Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. SHARMA AS, Flynn JR, Panageas KS, Shahrokni A, et al
   ASO Visual Abstract: Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma.
   Ann Surg Oncol. 2021 Jun 9. pii: 10.1245/s10434-021-10237.
   PubMed        
   
   
2. SHARMA AS, Flynn JR, Panageas KS, Shahrokni A, et al
   Assessment of Frailty Can Guide Decision Making for Utilization of Sentinel Lymph Node Biopsy in Patients with Thick Melanoma.
   Ann Surg Oncol. 2021 Jun 3. pii: 10.1245/s10434-021-10212.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. DALLE S, Mortier L, Corrie P, Lotem M, et al
   Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study.
   BMC Cancer. 2021;21:642.
   PubMed         Abstract available
   
   
4. DE FRANCA MNF, Isidorio RG, Bonifacio JHO, Dos Santos EWP, et al
   Anti-proliferative and pro-apoptotic activity of glycosidic derivatives of lawsone in melanoma cancer cell.
   BMC Cancer. 2021;21:662.
   PubMed         Abstract available
   
   
5. CAI YJ, Ke LF, Zhang WW, Lu JP, et al
   Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
   BMC Cancer. 2021;21:677.
   PubMed         Abstract available
   
   
6. SALMI S, Lin A, Hirschovits-Gerz B, Valkonen M, et al
   The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
   BMC Cancer. 2021;21:641.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

7. LAMBERT I, Fasolino G, Awada G, Kuijpers R, et al
   Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report.
   BMC Ophthalmol. 2021;21:250.
   PubMed         Abstract available
   
   

   
   Br J Cancer

8. WEBER A, Leitzmann MF, Sedlmeier AM, Baurecht H, et al
   Association between physical activity, grip strength and sedentary behaviour with incidence of malignant melanoma: results from the UK Biobank.
   Br J Cancer. 2021 May 31. pii: 10.1038/s41416-021-01443.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

9. WIGGINS J, Polsky D
   Melanoma origins: data from early-stage tumours supports de novo and naevus-associated melanomas as distinct subtypes.
   Br J Dermatol. 2021 Jun 11. doi: 10.1111/bjd.20396.
   PubMed        
   
   
10. YEH I, Bastian BC
    Melanoma pathology: new approaches and classification.
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20427.
    PubMed         Abstract available
    
    
11. MAHAMAT-SALEH Y
    Is consumption of citrus associated with a higher risk of melanoma?
    Br J Dermatol. 2021 May 31. doi: 10.1111/bjd.20408.
    PubMed        
    
    
12. AGRAWAL R, Tso S, Eltigani EA, Busam KJ, et al
    PRAME immunohistochemistry as an adjunct in the diagnosis of paucicellular lentigo maligna in a young man.
    Br J Dermatol. 2021;184:e122.
    PubMed        
    
    
13. GUHAN S, Klebanov N, Tsao H
    Melanoma genomics: a state-of-the-art review of practical clinical applications.
    Br J Dermatol. 2021 Jun 6. doi: 10.1111/bjd.20421.
    PubMed         Abstract available
    
    

    
    Cancer Res

14. HAN S, Yan Y, Ren Y, Hu Y, et al
    LncRNA SAMMSON Mediates Adaptive Resistance to RAF Inhibition in BRAF-Mutant Melanoma Cells.
    Cancer Res. 2021;81:2918-2929.
    PubMed         Abstract available
    
    
15. ZERHOUNI M, Martin AR, Furstoss N, Gutierrez VS, et al
    Dual covalent inhibition of PKM and IMPDH targets metabolism in cutaneous metastatic melanoma.
    Cancer Res. 2021 Jun 7. pii: 0008-5472.CAN-20-2114.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

16. BRASE JC, Walter RFH, Savchenko A, Gusenleitner D, et al
    Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib.
    Clin Cancer Res. 2021 Jun 9. pii: 1078-0432.CCR-20-3586.
    PubMed         Abstract available
    
    
17. MENZIES AM, Scolyer RA, Long GV
    Neoadjuvant immunotherapy in melanoma - the new frontier.
    Clin Cancer Res. 2021 Jun 3. pii: 1078-0432.CCR-21-1236.
    PubMed         Abstract available
    
    
18. DI GIACOMO AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, et al
    Primary analysis and four-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases.
    Clin Cancer Res. 2021 Jun 10. pii: 1078-0432.CCR-21-1046.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

19. CARR MJ, Monzon FA, Zager JS
    Sentinel lymph node biopsy in melanoma: beyond histologic factors.
    Clin Exp Metastasis. 2021 Jun 8. pii: 10.1007/s10585-021-10089.
    PubMed         Abstract available
    
    

    
    Cutis

20. ELIAS ML, John AM, Maddukuri S, Schwartz RA, et al
    Treatment Delay in Melanoma: A Risk Factor Analysis of an Impending Crisis.
    Cutis. 2021;107:E19-E26.
    PubMed         Abstract available
    
    

    
    Eur J Dermatol

21. ARNE V, Canan G, Marjan G
    A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients.
    Eur J Dermatol. 2021 Jun 2. pii: ejd.2021.4067. doi: 10.1684/ejd.2021.4067.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

22. NAVARRETE-DECHENT C, Liopyris K, Monnier J, Aleissa S, et al
    Reflectance confocal microscopy terminology glossary for melanocytic skin lesions: A systematic review.
    J Am Acad Dermatol. 2021;84:102-119.
    PubMed         Abstract available
    
    
23. GREEN AC, Hughes MCB, Williams GM, Malt M, et al
    Increased melanoma recurrence in patients with multiple primary invasive melanomas.
    J Am Acad Dermatol. 2021 May 27. pii: S0190-9622(21)01012.
    PubMed        
    
    
24. FIGUEROA-SILVA O, Suarez-Penaranda JM, Balboa-Barreiro V, Rojas SA, et al
    Volume tumor impact on melanoma survival assessed through Breslow density.
    J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01107.
    PubMed        
    
    
25. MUZUMDAR S, Lin G, Kerr P, Grant-Kels JM, et al
    Is Melanoma Overdiagnosed? A Review of the Evidence.
    J Am Acad Dermatol. 2021 Jun 8. pii: S0190-9622(21)01110.
    PubMed         Abstract available
    
    
26. BEAULIEU D, Gao DX, Swetter SM, Hawryluk EB, et al
    Association between income and suspected non-melanoma and melanoma skin cancers among participants of the American Academy of Dermatology's SPOT Skin Cancer(R) screening program - A cross-sectional analysis.
    J Am Acad Dermatol. 2021 Jun 2. pii: S0190-9622(21)01044.
    PubMed        
    
    

    
    J Clin Oncol

27. CHAPMAN PB
    Targeting Tumor-Rejection Antigens in Melanoma With Tumor-Infiltrating Lymphocytes.
    J Clin Oncol. 2021 Jun 4:JCO2101012. doi: 10.1200/JCO.21.01012.
    PubMed        
    
    

    
    J Surg Oncol

28. NARANG J, Hue JJ, Bingmer K, Hardacre JM, et al
    Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
    J Surg Oncol. 2021 Jun 9. doi: 10.1002/jso.26565.
    PubMed         Abstract available
    
    
29. DECKERS EA, Kruijff S, Bastiaannet E, van Ginkel RJ, et al
    Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.
    J Surg Oncol. 2021 Jun 4. doi: 10.1002/jso.26555.
    PubMed         Abstract available
    
    

    
    Melanoma Res

30. LAUWYCK J, Beckwee A, Santens A, Schwarze JK, et al
    C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting.
    Melanoma Res. 2021 May 28. pii: 00008390-900000000-99028.
    PubMed         Abstract available
    
    
31. KHULLAR K, Hanft S, Mehnert JM, Weiner JP, et al
    Complete response of brainstem metastasis in BRAF-mutated melanoma without stereotactic radiosurgery after initiation of encorafenib and binimetinib.
    Melanoma Res. 2021 May 28. pii: 00008390-900000000-99030.
    PubMed         Abstract available
    
    
32. HE H, Qiao B, Guo S, Cui H, et al
    Induction of T helper 17 cell response by interleukin-7 in patients with primary cutaneous melanoma.
    Melanoma Res. 2021 May 28. pii: 00008390-900000000-99031.
    PubMed         Abstract available
    
    
33. SANGSTER AB, Chang-McDonald B, Patel J, Bockett N, et al
    Expression of cathepsins B and D by cancer stem cells in head and neck metastatic malignant melanoma.
    Melanoma Res. 2021 Jun 10. pii: 00008390-900000000-99027.
    PubMed         Abstract available
    
    

    
    N Engl J Med

34. CURTI BD, Faries MB
    Recent Advances in the Treatment of Melanoma.
    N Engl J Med. 2021;384:2229-2240.
    PubMed        
    
    

    
    Oncol Rep

35. STACHYRA-STRAWA P, Ciesielka M, Janiszewski M, Grzybowska-Szatkowska L, et al
    The role of immunotherapy and moleculartargeted therapy in the treatment of melanoma (Review).
    Oncol Rep. 2021;46.
    PubMed         Abstract available
    
    

    
    Ophthalmol Retina

36. SHIELDS JA, Dockery PW, Shields CL
    Swiss Cheese-Appearing Cavitary Ciliochoroidal Melanoma.
    Ophthalmol Retina. 2021;5:592.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: